Helix BioPharma Corp. Provides Third Bi-Weekly MCTO Status Update

RICHMOND HILL, ON / ACCESSWIRE / November 30, 2021 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and

Related Keywords

Canada ,Toronto ,Ontario ,Richmond Hill ,Canadian ,Frank Michalargias ,Toronto Stock Exchange ,Helix Biopharma Corp ,Ontario Securities Commission Under National ,Helix Biopharma ,Ontario Securities Commission ,National Policy ,Cease Trade Orders ,Annual Filings ,Target Filing ,Chief Financial ,Looking Statements ,New Target Filing ,Annual Information Form ,Helix ,Iopharma ,Orp ,Rovides ,Third ,Weekly ,Cto ,Status ,Update ,